Alangcas, Jonard M.

HRN: 29-23-22  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2026
RIFAXIMIN 200MG (TAB)
07/02/2026
07/09/2026
ORAL
200mg
BID
Hepatic Encephalopathy
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: